NO20055097L - Krystallinske N-formyl-hydroksylaminforbindelser - Google Patents

Krystallinske N-formyl-hydroksylaminforbindelser

Info

Publication number
NO20055097L
NO20055097L NO20055097A NO20055097A NO20055097L NO 20055097 L NO20055097 L NO 20055097L NO 20055097 A NO20055097 A NO 20055097A NO 20055097 A NO20055097 A NO 20055097A NO 20055097 L NO20055097 L NO 20055097L
Authority
NO
Norway
Prior art keywords
compounds
crystalline
formyl
alkanes
hydroxylamine compounds
Prior art date
Application number
NO20055097A
Other languages
English (en)
Other versions
NO20055097D0 (no
Inventor
Joel Slade
Martin Mueller
Hui Liu
Joginder Singh Bajwa
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33131903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055097(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055097D0 publication Critical patent/NO20055097D0/no
Publication of NO20055097L publication Critical patent/NO20055097L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det beskrives visse N-formylhydroksylaminforbindelser som N-[I-okso-2-alkyl-3-(N-hydroksyformamido)-propyl]-(karbonylaminoaryl- eller -heteroaryl)-azasyklo4-7-alkaner eller -tiazasyklo4-7-alkaner eller -imidazasyklo4-7-alkaner. Forbindelsene finner anvendelse ved behandling av bakterielle infeksjoner. Det beskrives krystallinske salter av slike forbindelser med formel (I), der M er et en- eller toverdig metall og a er 1/2 eller 1.
NO20055097A 2003-04-02 2005-11-01 Krystallinske N-formyl-hydroksylaminforbindelser NO20055097L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45972603P 2003-04-02 2003-04-02
PCT/EP2004/003478 WO2004087133A1 (en) 2003-04-02 2004-04-01 Crystalline n-formyl hydroxylamine compounds

Publications (2)

Publication Number Publication Date
NO20055097D0 NO20055097D0 (no) 2005-11-01
NO20055097L true NO20055097L (no) 2005-12-22

Family

ID=33131903

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055097A NO20055097L (no) 2003-04-02 2005-11-01 Krystallinske N-formyl-hydroksylaminforbindelser

Country Status (25)

Country Link
US (1) US20070135353A1 (no)
EP (1) EP1613305A1 (no)
JP (1) JP2006522054A (no)
KR (1) KR20060002915A (no)
CN (1) CN1764450A (no)
AR (1) AR043804A1 (no)
AU (1) AU2004226815B2 (no)
BR (1) BRPI0409009A (no)
CA (1) CA2520682A1 (no)
CL (1) CL2004000705A1 (no)
CO (1) CO5630028A2 (no)
EC (1) ECSP056043A (no)
IS (1) IS8093A (no)
MA (1) MA27763A1 (no)
MX (1) MXPA05010610A (no)
MY (1) MY136854A (no)
NO (1) NO20055097L (no)
NZ (1) NZ542432A (no)
PE (1) PE20050392A1 (no)
RU (1) RU2005133660A (no)
SG (1) SG166681A1 (no)
TN (1) TNSN05248A1 (no)
TW (1) TW200427458A (no)
WO (1) WO2004087133A1 (no)
ZA (1) ZA200507179B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6987104B2 (en) 2001-06-15 2006-01-17 Vicuron Pharmaceuticals Inc. Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
KR20050057429A (ko) 2002-09-19 2005-06-16 노파르티스 아게 중간체의 제조 방법
EP1599440A2 (en) 2003-02-21 2005-11-30 Novartis AG Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds
GT200600196A (es) * 2005-05-23 2007-01-15 Compuestos n-formil de hidroxilamina
ES2930814T3 (es) * 2016-05-11 2022-12-22 Guangdong Hebo Pharmaceutical Co Ltd Inhibidor de péptido deformilasa de anillo espiro de tres miembros o anillo espiro de cinco miembros y uso del mismo como agente antitumoral

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282986A (en) * 1960-10-06 1966-11-01 Merck & Co Inc N-acylated hydroxamic acids and derivatives thereof
GB2349884A (en) * 1998-02-07 2000-11-15 British Biotech Pharm Antibacterial agents
AR036053A1 (es) * 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas

Also Published As

Publication number Publication date
BRPI0409009A (pt) 2006-03-28
AU2004226815B2 (en) 2007-07-19
NO20055097D0 (no) 2005-11-01
AU2004226815A1 (en) 2004-10-14
WO2004087133A1 (en) 2004-10-14
PE20050392A1 (es) 2005-06-19
ZA200507179B (en) 2006-04-26
EP1613305A1 (en) 2006-01-11
MY136854A (en) 2008-11-28
KR20060002915A (ko) 2006-01-09
CA2520682A1 (en) 2004-10-14
MA27763A1 (fr) 2006-02-01
RU2005133660A (ru) 2006-06-10
CL2004000705A1 (es) 2005-01-14
CN1764450A (zh) 2006-04-26
US20070135353A1 (en) 2007-06-14
AR043804A1 (es) 2005-08-10
SG166681A1 (en) 2010-12-29
TNSN05248A1 (en) 2007-06-11
ECSP056043A (es) 2006-01-27
JP2006522054A (ja) 2006-09-28
CO5630028A2 (es) 2006-04-28
IS8093A (is) 2005-10-27
NZ542432A (en) 2009-04-30
TW200427458A (en) 2004-12-16
MXPA05010610A (es) 2005-11-23

Similar Documents

Publication Publication Date Title
NO20051600L (no) 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
NO20062292L (no) Fremgangsmate for behandling av transplantasjonsavstoting
NO20051695L (no) Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer
NO20044534L (no) Substituerte fenylacetamider og deres anvendelse som glukokinaseaktivatorer
NO20054852L (no) GFAT inhibitorer
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
NO20050065L (no) Kjemiske forbindelser
NO20070606L (no) Inhibitorer av IAP
DK1558579T3 (da) N-alkyl-4-methylenamino-3-hydroxy-2-pyridoner som antimikrobialer
NO20055680L (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
NO20034661L (no) Nociceptin-analoger
NO20083006L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av fedme
HRP20090159T1 (en) Use of glucosidase inhibitors for therapy of mucovisidosis
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
NO20062629L (no) Oksazolderivater av tetrackliner
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
NO20055097L (no) Krystallinske N-formyl-hydroksylaminforbindelser
SE0203304D0 (sv) Novel Coumpounds
NO20044549L (no) Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
NO20060733L (no) Pyrazoliner som PAR-1 antagonister for behandling av kardiovaskulaere sykdommer
SE9803773D0 (sv) Compounds
DE60118732D1 (de) EIN KOMBINATIONSPRODUKT ENTHALTEND MELAGATRAN UND EINEN FAKTOR Xa INHIBITOR
NO20012831L (no) Diazepinoindoler for behandling av kronisk obstruktiv lungesykdom
NO20062307L (no) Spirofuropyridinarylderivater
HRP20090187T1 (en) Bengamide derivatives and use thereof for the treatment of cancer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application